SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): August 16, 2004
Equistar Chemicals, LP
(Exact name of registrant as specified in its charter)
Delaware | 333-76473 | 76-0550481 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
1221 McKinney Street
Suite 700, Houston, Texas 77010
(Address of principal executive offices and zip code)
Registrant’s telephone number, including area code: 713-652-7200
Item 5. Other Events.
On August 16, 2004 Equistar Chemicals, LP (“Equistar”) announced that it has resumed making distributions to its owners, distributing a total of $100 million to Lyondell Chemical Company (“Lyondell”) and Millennium Chemicals Inc. (“Millennium”). Lyondell owns a 70.5% interest in Equistar, and Millennium owns the remaining 29.5% interest. Equistar’s August 16, 2004 press release regarding the distributions is being filed with this Current Report on Form 8-K as Exhibit 99.1.
Item 7. Financial Statements and Exhibits.
(c) | Exhibits. |
99.1 | Press Release |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Equistar Chemicals, LP | ||
By: | /s/ Charles L. Hall | |
Charles L. Hall | ||
Vice President, Controller and Chief Accounting Officer |
Date: August 16, 2004
INDEX TO EXHIBITS
Exhibit Number | Description | |
99.1 | Press Release |